Scientists at Sanford Burnham Prebys Medical Discovery Institute and Duke-National University of Singapore (NUS) Medical School have reported new findings on how stem cells can help repair brain damage after a stroke. The study, published January 8, 2026, in Cell Stem Cell, tested a therapy using human stem cells transplanted into mice. The researchers found that the transplanted cells matured, integrated into existing neural circuits, and helped restore function.
One of the main challenges for regenerative medicine in treating stroke is the hostile environment left behind in the adult brain after injury. Su-Chun Zhang, MD, PhD, who holds the Jeanne and Gary Herberger Leadership Chair in Neuroscience at Sanford Burnham Prebys and serves as director and professor in its Center for Neurologic Diseases, explained: "In the adult brain after a stroke, you see the formation of a cyst, a cavity that is filled with all sorts of inflammatory molecules, so it is a bit like the therapeutic cells are swimming in a dangerous swamp full of threats." He added: "If that wasn't enough, scar tissue surrounds the cavity to protect the brain from further damage, but it also forms a barrier against any potential regeneration."
Some approaches attempt to graft new cells near damaged regions to bypass them. However, Zhang emphasized that healing should focus on repairing trauma directly: "Following a stroke, the damaged lesion is often very large and presents an immense challenge to efforts to functionally reconnect the brain to the brain stem and spinal cord."
To address this issue, Zhang's team developed a method using small molecule drugs and structural proteins to support survival of therapeutic cells placed directly into stroke-damaged areas. They observed that these transplanted cells survived and grew within this harsh environment.
The researchers then examined whether these new neurons could form correct connections within existing brain circuits. According to Zhang: "We found that different types of transplanted neurons found their own partners even in the complicated context of the mature brain environment. They still can find their targets in a very specific manner." Three-dimensional reconstructions showed that neuron projections resembled those seen between healthy cerebral cortex and spinal cord pathways.
To better understand how regenerated neurons navigate inside the brain, scientists used genetic barcodes to label transplanted cells along with gene expression sequencing data. Zhang said: "We revealed that each cell type has its own code and, once the cells become neurons, this code tells each cell to send its projections or axons to different parts of the brain and spinal cord." He continued: "It's the first time this striking phenomenon has been reported, and it is significant because it basically tells us that if we have the right types of transplanted cells, they already know where to go and what to do to repair what has been lost."
Machine learning was used by researchers to identify four subtypes of neurons developing from therapeutic stem cells. Each subtype expressed genes guiding axon growth differently; most neurons within one subtype sent axons toward similar regions.
The team also tested how gene-regulating proteins called transcription factors affect neuron projection patterns by removing one such factor (Ctip2) from some stem cell samples before transplantation. These modified neurons showed altered projection patterns compared with unmodified ones—more axons targeted areas like hippocampus or amygdala.
Zhang concluded: "By learning more about these subtypes of transplanted neurons, we may be able to predict their projections and connectivity in order to select appropriate neuronal cell types for targeted circuit reconstruction in patients." He added: "It opens a promising future for cell therapy to help the millions of people that suffer from stroke and other devastating neurological conditions."
